Antibodies News and Research

RSS

West Nile Virus returns to United States for another season

The winter cold and flu season is barely over, and the new mosquito season won't really get rolling for a few more weeks, but the Centers for Disease Control and Prevention (CDC) already is reporting the presence of West Nile Virus in mosquitoes, birds and other animals in nine states.

5 May 2004

Study identifies key factor causing low iron and anemia in patients with infections and major inflammatory diseases

UCLA researchers found that a member of the immune system’s defense team stimulates a chain reaction leading to chronic anemia in many patients with infections and major inflammatory diseases.

3 May 2004

Wyeth gets FDA approval for a novel protein device that enhances bone healing

Wyeth have announced that the FDA has approved rhBMP-2/ACS (recombinant human Bone Morphogenetic Protein-2/Absorbable Collagen Sponge), a novel protein device that enhances bone healing, for use in the treatment of acute, open tibia shaft fractures in adults.

3 May 2004

Chlamydia may cause infertility in men as well as long-term health problems for women

Swedish study suggests Chlamydia the most common sexually transmitted infection might cause infertility in men as well as long-term health problems for women.

29 Apr 2004

PET imaging has recently been shown to aid in the diagnosis of particular neurological syndromes associated with cancer

PET imaging has been shown to improve detection of a variety of cancers, and earlier tests have suggested this technique may be useful in identifying small tumors in patients with paraneoplastic neurological disorders. But PET imaging is not yet widely available, and clear indicators of clinically meaningful outcomes using PET are essential to warrant use with this patient population.

28 Apr 2004

Experimental smallpox DNA vaccine

In the first successful study of its kind, scientists have shown that a DNA-based vaccine for smallpox can protect nonhuman primates from monkeypox, a disease that resembles smallpox in humans.

27 Apr 2004

SARS antibody sent to China

Responding to a request from a Chinese biotechnology company working closely with officials in China, Medarex, Inc. and the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) have shipped to Beijing a sample of the fully human antibody to SARS developed by Medarex and MBL/UMMS.

26 Apr 2004

Los Angeles health officials urge public to take preventative measures against West Nile virus

Los Angeles health officials have issued a statement urging the public to take precautions against mosquitoes after crows in the county tested positive for the West Nile virus. "These findings are a clear warning that the virus is continuing to circulate and amplify in the environment. Now is the time to take precautions," said Steve West of the San Gabriel Valley Mosquito and Vector Control District.

24 Apr 2004

Overview of West Nile virus before season starts

West Nile virus is a newly emergent virus of the family Flaviviridae, found in both tropical and temperate regions. It mainly infects birds, but is also the cause of a number of conditions in humans, horses, and some other mammals. It is transmitted by bites of infected mosquitoes.

24 Apr 2004

Severe Acute Respiratory Syndrome (SARS) overview

Severe Acute Respiratory Syndrome (SARS) is an atypical form of pneumonia that first appeared in November 2002 in Guangdong Province, China.

24 Apr 2004

First Chinese case of case of SARS since January 2004

On April 22, 2004, the Chinese Ministry of Health reported a possible case of severe acute respiratory syndrome (SARS) in a 20-year-old woman who works as a nurse in a hospital in Beijing. If confirmed, this will be the first case of SARS since January 2004, when Chinese health authorities confirmed SARS coronavirus (SARS-CoV) infection in three persons in Guangdong Province.

23 Apr 2004

Possible new SARS case in Beijing, China

22 Apr 2004

Possible breakthrough in AIDS and cancer research

Mayo Clinic researchers have found a way to revive immunity in mice that have abnormal or deficient immune systems. The discovery may lead to a means of restoring immunity to individuals with immunodeficiency diseases such as AIDS and cancer.

20 Apr 2004

An experimental vaccine based on a critical piece of the SARS virus

An experimental vaccine based on a critical piece of the SARS virus protects mice from SARS infection, researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have found.

19 Apr 2004

Cancer-specific protein offers new target for the development of melanoma vaccine

Scientists from the Cancer Vaccine Collaborative (CVC) have discovered that the cancer-specific protein, SSX-2, induces a spontaneous immunological reaction against cancer cells in melanoma patients, offering a new target for the development of a therapeutic melanoma vaccine. SSX-2 is the prototype of the SSX family, and is part of a larger group of proteins known as cancer/testis (CT) antigens.

16 Apr 2004

New nose cancer test kit promises to simplify the process and speed cancer testing

Inflexion a Singapore based offshoot of Nanyang Technological University has announced a new kit to test for and diagnose nose cancer. The kit was prepared some 3 years ago and had been forgotten until 3 young entrepreneurs realised it's commercial potential.

12 Apr 2004

More evidence needed to link symptoms like tics or behavioral problems to a strep infection

T-cells in lupus patients avoid apoptosis and are stimulated to produce antibodies against the patients own DNA

Researchers studying autoimmune diseases have found a molecular mechanism that explains how T-cells in lupus patients avoid apoptosis and are stimulated to produce antibodies against the patients own DNA.

1 Apr 2004

SARS virus vaccine stimulates protective immune response

An experimental vaccine prevents the SARS virus from replicating in laboratory mice, according to a new report in the April 1 issue of Nature. Scientists at the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, developed the vaccine. The vaccine was tested in a mouse model of SARS infection recently validated by other NIAID investigators.

31 Mar 2004

DakoCytomation has acquired exclusive worldwide rights to develop and commercialize pharmacogenomic diagnostic tests in the field of oncology

Human Genome Sciences, Inc. announced today a license agreement with DakoCytomation A/S (Glostrup, Denmark), under which DakoCytomation has acquired exclusive worldwide rights to develop and commercialize pharmacogenomic diagnostic tests in the field of oncology based on the TRAIL Receptor-1 (TRAIL-R1) and TRAIL Receptor-2 (TRAIL-R2) proteins.

31 Mar 2004

Antibodies News and Research

West Nile Virus returns to United States for another season

Study identifies key factor causing low iron and anemia in patients with infections and major inflammatory diseases

Wyeth gets FDA approval for a novel protein device that enhances bone healing

Chlamydia may cause infertility in men as well as long-term health problems for women

PET imaging has recently been shown to aid in the diagnosis of particular neurological syndromes associated with cancer

Experimental smallpox DNA vaccine

SARS antibody sent to China

Los Angeles health officials urge public to take preventative measures against West Nile virus

Overview of West Nile virus before season starts

Severe Acute Respiratory Syndrome (SARS) overview

First Chinese case of case of SARS since January 2004

Possible new SARS case in Beijing, China

Possible breakthrough in AIDS and cancer research

An experimental vaccine based on a critical piece of the SARS virus

Cancer-specific protein offers new target for the development of melanoma vaccine

New nose cancer test kit promises to simplify the process and speed cancer testing

More evidence needed to link symptoms like tics or behavioral problems to a strep infection

T-cells in lupus patients avoid apoptosis and are stimulated to produce antibodies against the patients own DNA

SARS virus vaccine stimulates protective immune response

DakoCytomation has acquired exclusive worldwide rights to develop and commercialize pharmacogenomic diagnostic tests in the field of oncology

Immunology eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News